Skip to main content
SpringerLink
Log in

Kasuistik eines Patienten mit multifokalem Glioblastomrezidiv

Deutliches Ansprechen auf CAR-T-Zell-Therapie

  • journal club
  • Published:
InFo Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Brown et al. N Engl J Med 2016;s375:2561–9.

    Article  Google Scholar 

Originalie

  • Brown CE et al. Regression of glioblastoma after chimeric antigen receptor T-cell therapy. N Engl J Med 2016;s375:2561–9.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Neurologie, Universitätsklinikum Essen, Essen, Deutschland

    Martin Glas (Leiter Abteilung Klinische Neuroonkologie)

Authors
  1. Martin Glas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Martin Glas.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Glas, M. Deutliches Ansprechen auf CAR-T-Zell-Therapie. Info Onkol. 20, 20–22 (2017). https://doi.org/10.1007/s15004-017-5846-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15004-017-5846-x

Schlüsselwörter

Search

Navigation